LAUSR

Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study

Sign Up to like & get
recommendations!
1 Published in 2022 at "Helicobacter"

DOI: 10.1111/hel.12896

Abstract: Vonoprazan‐amoxicillin (VA) dual therapy has been shown to achieve acceptable cure rates for treatment of Helicobacter pylori(H. pylori) in Japan. Its effectiveness in other regions is unknown. We aimed to explore the efficacy of VA… read more here.

Keywords: therapy; dual therapy; vonoprazan amoxicillin; amoxicillin dual ... See more keywords